Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ledent

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Archives D'Anatomie Et De Cytologie Pathologiques|October 1, 1998
[Thyroid insular carcinoma]B Franc, C Ledent, P P de Saint-Maur, et al.
Neuroscience|January 5, 2000
Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptorsG A Bohme, M Laville, C Ledent, et al.
The European Journal of Neuroscience|October 31, 2002
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxietyJ Haller, N Bakos, M Szirmay, et al.
European Journal of Pharmacology|August 1, 2000
SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptorM El Yacoubi, C Ledent, M Parmentier, et al.
Oncogene|May 4, 1995
Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgeneC Ledent, A Marcotte, J E Dumont, et al.
The European Journal of Neuroscience|April 14, 2004
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in miceJ Haller, B Varga, C Ledent, et al.
Behavioural Pharmacology|September 9, 2005
Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophreniaJ Haller, M Szirmai, B Varga, et al.
Allergy|June 8, 2000
Early effect of ultrarush venom immunotherapy on the IgG antibody responseA Michils, S Baldassarre, C Ledent, et al.
Neuropharmacology|October 18, 2002
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinenceA Castañé, E Valjent, C Ledent, et al.
Neuroreport|October 24, 2000
Regulation of nociceptin mRNA expression in the septum by dopamine and adenosine systemsD Dassesse, C Ledent, J C Meunier, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Archives D'Anatomie Et De Cytologie Pathologiques|October 1, 1998
[Thyroid insular carcinoma]B Franc, C Ledent, P P de Saint-Maur, et al.
Neuroscience|January 5, 2000
Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptorsG A Bohme, M Laville, C Ledent, et al.
The European Journal of Neuroscience|October 31, 2002
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxietyJ Haller, N Bakos, M Szirmay, et al.
European Journal of Pharmacology|August 1, 2000
SCH 58261 and ZM 241385 differentially prevent the motor effects of CGS 21680 in mice: evidence for a functional 'atypical' adenosine A(2A) receptorM El Yacoubi, C Ledent, M Parmentier, et al.
Oncogene|May 4, 1995
Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgeneC Ledent, A Marcotte, J E Dumont, et al.
The European Journal of Neuroscience|April 14, 2004
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in miceJ Haller, B Varga, C Ledent, et al.
Behavioural Pharmacology|September 9, 2005
Cannabinoid CB1 receptor dependent effects of the NMDA antagonist phencyclidine in the social withdrawal model of schizophreniaJ Haller, M Szirmai, B Varga, et al.
Allergy|June 8, 2000
Early effect of ultrarush venom immunotherapy on the IgG antibody responseA Michils, S Baldassarre, C Ledent, et al.
Neuropharmacology|October 18, 2002
Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinenceA Castañé, E Valjent, C Ledent, et al.
Neuroreport|October 24, 2000
Regulation of nociceptin mRNA expression in the septum by dopamine and adenosine systemsD Dassesse, C Ledent, J C Meunier, et al.
Pageof 10